Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Oslo, 15 February 2024 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announced its results for the fourth quarter and for the full year 2023. Revenues for the year was up 34 per cent to NOK 512 million, mainly by organic growth. For the first time all three product categories were above the NOK 100 million mark.The company’s gross margin was 38.9 per cent for the year, down from 42.8 per cent in the year before. Adjusted EBITDA (EBITDA less acquisition cost) amounted to NOK 51.6 million, compared with

Peab builds railway sidings in Gothenburg

Peab has been commissioned to build new railway sidings in Lärje, north of Gothenburg, for local and regional trains. The customer is the Swedish Transport Administration and the contract is worth SEK 392 million.The project is part of the Swedish Transport Administration’s program to increase capacity and accessibility for train traffic in the Gothenburg area. The opening of Västlänken will change train traffic and more trains will need to be stored when not in use. Lärje has been identified as suitable place for a siding primarily due to its proximity to the central railway network,

Careium reports fourth quarter results 2023

The quarter in summary · Net sales amounted to SEK 199.4 million (196.2), an increase of 1.7 percent. Service sales amounted to 154.1 million (145.1), an increase of 6.2 percent. Product sales amounted to 45.3 million (51.1), a decrease of 11.3 percent. · Gross margin amounted to 40.2 percent (39.4). · Operating profit (EBIT) amounted to SEK 16.7 million (13.2), corresponding to an operating margin of 8.4 percent (6.7). The EBIT last year was positively affected by SEK 3.9 million from non-recurring items. · Free cash flow amounted to SEK 35.8 million (-53.4). · Earnings

INSIDE INFORMATION: Tietoevry’s strategic review of its Banking business: Tietoevry’s Board of Directors has approved a demerger plan

Tietoevry Corporation   INSIDE INFORMATION   15 February 2024, 9:00 a.m. EET   NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE OR ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   INSIDE INFORMATION: Tietoevry’s strategic review of its Banking business: Tietoevry’s Board of Directors has approved a demerger plan   · Separation process of Tietoevry Banking continues: demerger plan concerning a partial demerger of

Prostatype Genomics publishes year-end report for 2023

Prostatype Genomics AB today publishes its year-end report for the full year 2023, including the interim report for the second half of 2023. The full year-end report is attached and can also be downloaded from the company’s website, www.prostatypegenomics.com.Summary of the second half of the year and the full year 2023 Second half of 2023, 1 July 2023 – 31 December 2023• Net sales amounted to 908 TSEK (414)• EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -17,797 TSEK (-14,849)• Cash flow from current operations amounted to -9,938 TSEK (-16,386)

Optomed Plc: Financial Statements Bulletin, January – December 2023

Optomed Plc         Stock Exchange Release    15 February 2024 at 9:00, Helsinki Optomed Plc: Financial Statements Bulletin, January – December 2023 October – December 2023 · Revenue decreased by 8.8 percent to EUR 3.7 (4.0) million. · Devices segment revenue decreased by 19.8 percent to EUR 1.0 (1.3) million. · Software segment revenue decreased by 3.7 percent to EUR 2.6 (2.7) million. · EBITDA and adjusted EBITDA amounted to EUR -0.8 (-0.3) million corresponding to -20.7 (-8.7) percent of revenue. · Optomed expects its full year 2024 revenue to grow compared to 2023.

Interim report January - December 2023

Summary of a new record year Quarter 4, 2023   · Orders received amounted to SEK 1,467m (1,396), equivalent to currency neutral growth of 4.8 percent compared with the same period last year. · Net sales amounted to SEK 1,501m (1,515), equivalent to a currency neutral decline of 0.8 percent compared with the same period last year. · Adjusted EBITA was SEK 171.6m (161.1), giving an adjusted EBITA margin of 11.4 percent (10.6). · Operating profit amounted to SEK 149.2m (136.8), corresponding to an operating margin of 9.9 percent (9.0). · Net profit was SEK 77.3m (90.9).

Raute Corporation Financial Statements Release January 1-December 31, 2023

RAUTE CORPORATION FINANCIAL STATEMENTS RELEASE FEBRUARY 15, 2024, AT 9:00 A.M.   RAUTE CORPORATION FINANCIAL STATEMENTS RELEASE JANUARY 1-DECEMBER 31, 2023   This is a summary of Raute’s Financial statements release January 1 – December 31, 2023. The full report is a PDF file attachment to this stock exchange release and is also available on the company's website at www.raute.com.   October-December 2023 · Order intake was EUR 118 million (28) · Order book was EUR 266 million (84) at the end of the reporting period · Net sales were EUR 45.2 million (45.7) ·

Kojamo's Board of Directors resolved on a new plan period 2024-2026 in the key employee long-term incentive scheme

Kojamo plc Stock Exchange Release, 15 February 2024 at 8:45 a.m. EETKojamo's Board of Directors resolved on a new plan period 2024-2026 in the key employee long-term incentive scheme The Board of Directors of Kojamo plc resolved on the commencement of a new plan period in the share-based long-term incentive scheme targeted to the company's key employees. It comprises a performance-based long-term incentive plan ("PSP") targeted to Kojamo's management and selected key employees and a restricted share plan ("RSP") which serves as a complementary share-based retention plan for specific

Capitainer Secures SEK 30 Million Investment from We Venture Capital to Expand and Innovate in Self-Sampling Solutions

Capitainer is proud to announce a significant financial investment of SEK 30 million from We Venture Capital, the venture capital arm of the globally renowned Werfen Group. This strategic investment marks a milestone in Capitainer's journey towards becoming the foremost provider of self-sampling solutions.We Venture Capital, the venture capital arm of Werfen Group which reported a turnover of 1.84 billion dollars in 2022, specializes in empowering innovative companies at the forefront of diagnostic technology. This investment aligns with their mission of transforming patient-oriented

Kid ASA - Key information relating to payment of cash dividend

* Dividend amount: NOK 3.50 per share * Declared currency: NOK * Last day including right: 14 May 2024 * Ex-date: 15 May 2024 * Record date: 16 May 2024 * Payment date: 29 May 2024 * Date of approval: 14 May 2024 (The Annual General Meeting) This information is published in accordance with the requirements of the Continuing Obligations and is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act.

Glaston’s Financial Statement Bulletin January 1 – December 31, 2023: Steady improvement in profitability throughout 2023

GLASTON CORPORATION   FINANCIAL STATEMENT BULLETIN         15 FEBRUARY 2024 AT 8.30This release is a summary of Glaston Corporation's financial statements bulletin for 2023. The complete report is attached to this release as a pdf-file. The stock exchange release is also available on the company's website at the address www.glaston.net. As of October 1, 2023, Glaston has two reporting segments: Architecture and Mobility, Display & Solar. Services business is included in the reporting segments. On November 24, 2023, the company published comparative information according to the new

Betsson AB (publ) year-end report 1 January - 31 December 2023

QUARTER OCTOBER - DECEMBER 2023 · Group revenue was EUR 251.9 (220.6) million, an increase of 14%. Organic increase of 36%. · Casino revenue increased by 25%. Sportsbook revenue decreased by 5% and the sportsbook margin was 6.2% (7.3%).  · EBITDA was EUR 71.9 (51.1) million, an increase of 40%. The EBITDA margin was 28.6% (23.2%). · Operating income (EBIT) was EUR 57.0 (40.0) million, an increase of 42%. The EBIT margin was 22.6% (18.1%). · Net income was EUR 43.3 (32.7) million, corresponding to EUR 0.30 (0.26) per share. · Operating cash flow was EUR 47.6 (75.5)

Interim Report October–December 2023

Strong order book momentum, improved cash flow and proposed higher dividend.• Net sales increased by 2 percent to SEK 8,106 million (7,945)• The order backlog was SEK 17,000 million (16,881)• EBITA decreased by 11 percent to SEK 597 million (669)• The EBITA margin was 7.4 percent (8.4)• Profit after tax was SEK 413 million (501)• Cash flow from operating activities was SEK 1,435 million (1,110)• Net debt amounted to SEK -2,193 million (-1,304)• Five acquisitions were completed during the quarter, adding annual sales of approximately SEK 979 million• Basic earnings per share

Kid ASA – Fourth Quarter 2023 Results

Lier, 15 February 2024: The Board of Directors of Kid ASA has approved the financial report for the fourth quarter of 2023. KEY FINANCIAL HIGHLIGHTS: · All-time high revenues and EBITDA in Q4. · Group revenues increased by 13.0% to MNOK 1,253.2, representing second consecutive quarter of double-digit growth. · New products and categories remain a significant growth driver. Revenues from Extended assortment was MNOK 14.6 in the quarter. · Gross margin increased by 6.5 percentage points to 63.4%. · Operating expenses relative to sales (excl. IFRS 16) in Q4 was 36.7% (36.7%)

Checkin.com Group Year-end report 2023

Checkin.com Group (STO:CHECK) reports MSEK 16 in cash flow from operating activities and 38% organic growth during the fourth quarter of 2023. The report in brief: FY 2023 (vs FY 2022): · Net revenue increased to KSEK 96,987 (70,187) which corresponds to a growth of 38 (81)%, of which 37 (55)% was organic. · Gross profit for the period amounted to KSEK 79,690 (59,952) with a margin of 82 (85)%. · EBITDA for the period amounted to KSEK 27,204 (5,509) with a margin of 28 (8)%. · Cash flow from operating activities amounted to KSEK 24,627 (2,898). · Net Revenue Retention

Fondia Plc: Financial Statements Release 2023 – growth despite market challenges, productivity to be improved

Fondia Plc Company relase 15.2.2024 at 8.30 a.m. EET FINANCIAL DEVELOPMENT IN BRIEF Figures in parentheses refer to the corresponding period of the previous year, unless otherwise stated. July–December 2023 summary: · Net sales EUR 12.6 million (12.3), a change of 1.8% · EBITDA EUR 1.4 million (1.7) · EBITDA-% 11.4% (13.5) · Operating profit (EBIT) EUR 1.0 million (1.2) · Operating profit-% (EBIT-%) 7.9% (10.0) · Profit for the period EUR 0.7 million (1.0) · Continuous monthly invoicing accounted for 47% (47) of net sales · Personnel (period average

SLP revises financial risk limitations

SLP’s Board of Directors has evaluated the company's strategy and can conclude that the company's growth since the start in 2019, with 56 transactions of development logistics properties in southern Sweden, has been very successful. The company has exceeded its overarching goals without being near the financial risk limitations. The board has made the assessment that the overarching goals can be achieved going forward even if the risk level in two of the company's three financial risk limitations is lowered.Overarching goals • To generate an average annual growth in net asset value (NAV)

Saga Pure: Fourth quarter 2023 financial results

(Oslo, 15 February 2024) Saga Pure ASA (Saga Pure, OSE: SAGA) reported a net loss in the fourth quarter 2023 of NOK 1 million (Q4 2022: Loss of NOK 101 million), giving a return on equity of minus 9.9 percent year to date. For the full year of 2023 Saga had loss of NOK 99 million (2022: Loss of NOK 24 million). Saga Pure continues to implement the expanded investment mandate with a focus on capital discipline and selective investments.For the fourth quarter 2023, Saga Pure reported a net loss of NOK 1 million (Q4 2022: Loss of NOK 101 million). Saga had in the fourth quarter a gain on short

Kojamo plc’s Financial Statements and Board of Directors’ Report 2023 have been published

Kojamo plc Stock Exchange Release, 15 February 2024 at 8:30 a.m. EETKojamo plc’s Financial Statements and Board of Directors’ Report 2023 have been published Kojamo plc’s Financial Statements and Board of Directors’ Report 2023 have been published today. The Financial Statements includes the consolidated financial statements, the parent company financial statements and the Auditor’s Report. In addition, the company has today published separate Corporate Governance Statement and Remuneration Report for the year 2023. The Financial Statements are published in accordance with the

Year-end report January – December 2023

October – December 2023 · Net sales increased by 2 percent to SEK 7,532m (7,361). · Gross profit increased by 5 percent to SEK 2,526m (2,416). · EBITDA rose by 3 percent to SEK 818m (791). · Adjusted EBITDA[1] increased by 4 percent to SEK 996m (960). · Profit after tax for the quarter amounted to SEK 145m (-226). · Basic earnings per share were SEK 0.17 (-0.27) and diluted earnings per share were SEK 0.17 (-0.27). · Cash flow from operating activities amounted to SEK 727m (973). January – December 2023 · Net sales increased by 4 percent to SEK 28,745m (27,722)

Sciety’s portfolio company Capitainer secures SEK 30 million investment from We Venture Capital, part of the Werfen Group

Sciety’s portfolio company Capitainer, a Swedish medtech company that develops intelligent solutions for self-sampling of blood and plasma, has received a SEK 30 million investment from We Venture Capital, the venture capital arm of the globally renowned Werfen Group. This strategic investment marks a milestone in Capitainer's journey towards becoming the leading provider of self-sampling solutions.We Venture Capital, the venture capital arm of Werfen Group, specialises in empowering innovative companies at the forefront of diagnostic technology. This investment aligns with their mission of

Tietoevry: continued focus on recovery from the ransomware attack

Tietoevry Corporation     PRESS RELEASE     15 February 2024   8.30 a.m. EET The ransomware attack on one of Tietoevry’s data centers in Sweden took place during the night of January 19-20. Tietoevry was able to stop the attack and limit the impact to one platform which was immediately isolated from other Tietoevry infrastructure. The attack has not affected other parts of the company’s infrastructure. Tietoevry sincerely regrets the inconvenience caused by this criminal attack to our customers and all those affected by it. Owing to the diverse profiles of the directly impacted

Skanska builds data center in Arizona, USA, for USD 87M, about SEK 900M

Skanska has signed a contract with an existing client to build a data center in Arizona, USA. The contract is worth USD 87M, about SEK 900M, which will be included in the US order bookings for the first quarter of 2024.The project consists of a single-story data center, totalling approximately 22,300 square meters (240,000 square feet). Work is underway and is scheduled for completion in the second quarter of 2025.

There are no items matching the current filter
There are no more items matching the current filter
Back to top